HALO Actualités Forex
Halozyme Therapeutics Boosts FY24 Outlook On Grant Of European Patent
Biopharmaceutical company Halozyme Therapeutics, Inc. (HALO) announced Thursday that it is raising its full year 2024 financial guidance based on the grant of European Patent No. 4269578.
RTTNews
|
il y a 154
